Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Cytometry-based analysis of HLA-G functions according to ILT2 expression.

Jacquier A, Dumont C, Carosella ED, Rouas-Freiss N, LeMaoult J.

Hum Immunol. 2020 Feb 18. pii: S0198-8859(19)31390-4. doi: 10.1016/j.humimm.2020.02.001. [Epub ahead of print]

PMID:
32081570
2.

Are the Immune Properties of Mesenchymal Stem Cells from Wharton's Jelly Maintained during Chondrogenic Differentiation?

Voisin C, Cauchois G, Reppel L, Laroye C, Louarn L, Schenowitz C, Sonon P, Poras I, Wang V, D Carosella E, Benkirane-Jessel N, Moreau P, Rouas-Freiss N, Bensoussan D, Huselstein C.

J Clin Med. 2020 Feb 4;9(2). pii: E423. doi: 10.3390/jcm9020423.

3.

Influence of hormones on the immunotolerogenic molecule HLA-G: a cross-sectional study in patients with congenital adrenal hyperplasia.

Nguyen LS, Rouas-Freiss N, Funck-Brentano C, Leban M, Carosella ED, Touraine P, Varnous S, Bachelot A, Salem JE.

Eur J Endocrinol. 2019 Nov;181(5):481-488. doi: 10.1530/EJE-19-0379.

PMID:
31505456
4.

CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G.

Dumont C, Jacquier A, Verine J, Noel F, Goujon A, Wu CL, Hung TM, Desgrandchamps F, Culine S, Carosella ED, Rouas-Freiss N, LeMaoult J.

Cancer Immunol Res. 2019 Oct;7(10):1619-1632. doi: 10.1158/2326-6066.CIR-18-0764. Epub 2019 Aug 26.

PMID:
31451484
5.

High level of soluble human leukocyte antigen (HLA)-G at beginning of pregnancy as predictor of risk of malaria during infancy.

d'Almeida TC, Sadissou I, Sagbohan M, Milet J, Avokpaho E, Gineau L, Sabbagh A, Moutairou K, Donadi EA, Favier B, Pennetier C, Baldet T, Moiroux N, Carosella E, Moreau P, Rouas-Freiss N, Cottrell G, Courtin D, Garcia A.

Sci Rep. 2019 Jun 24;9(1):9160. doi: 10.1038/s41598-019-45688-w.

6.

HLA-G expression during hookworm infection in pregnant women.

Avokpaho E, d'Almeida TC, Sadissou I, Tokplonou L, Adamou R, Sonon P, Milet J, Cottrell G, Mondière A, Massougbodji A, Moutairou K, Donadi EA, Teixeira Mendes Junior C, Favier B, Carosella E, Moreau P, Rouas-Freiss N, Garcia A, Courtin D.

Acta Trop. 2019 Aug;196:52-59. doi: 10.1016/j.actatropica.2019.04.026. Epub 2019 May 9.

PMID:
31078470
7.

Biological functions of mesenchymal stem cells and clinical implications.

Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N.

Cell Mol Life Sci. 2019 Sep;76(17):3323-3348. doi: 10.1007/s00018-019-03125-1. Epub 2019 May 4. Review.

PMID:
31055643
8.

Mesenchymal stem/stromal cell function in modulating cell death.

Naji A, Favier B, Deschaseaux F, Rouas-Freiss N, Eitoku M, Suganuma N.

Stem Cell Res Ther. 2019 Feb 13;10(1):56. doi: 10.1186/s13287-019-1158-4. Review.

9.

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells.

Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M, de Gouvello A, Dumont C, Wu CL, Culine S, Verine J, Rouas-Freiss N, Hennequin C, Masson-Lecomte A, Carosella ED.

Oncotarget. 2018 Sep 4;9(69):33160-33169. doi: 10.18632/oncotarget.26036. eCollection 2018 Sep 4.

10.

The genetic diversity within the 1.4 kb HLA-G 5' upstream regulatory region moderately impacts on cellular microenvironment responses.

Dias FC, Bertol BC, Poras I, Souto BM, Mendes-Junior CT, Castelli EC, Gineau L, Sabbagh A, Rouas-Freiss N, Carosella ED, Donadi EA, Moreau P.

Sci Rep. 2018 Apr 4;8(1):5652. doi: 10.1038/s41598-018-24009-7.

11.

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

Rouas-Freiss N, LeMaoult J, Verine J, Tronik-Le Roux D, Culine S, Hennequin C, Desgrandchamps F, Carosella ED.

Oncoimmunology. 2017 Jul 5;6(9):e1342023. doi: 10.1080/2162402X.2017.1342023. eCollection 2017.

12.

Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.

Tronik-Le Roux D, Renard J, Vérine J, Renault V, Tubacher E, LeMaoult J, Rouas-Freiss N, Deleuze JF, Desgrandschamps F, Carosella ED.

Mol Oncol. 2017 Nov;11(11):1561-1578. doi: 10.1002/1878-0261.12119. Epub 2017 Sep 13.

13.

Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight.

d'Almeida TC, Sadissou I, Milet J, Cottrell G, Mondière A, Avokpaho E, Gineau L, Sabbagh A, Massougbodji A, Moutairou K, Donadi EA, Favier B, Carosella E, Moreau P, Rouas-Freiss N, Courtin D, Garcia A.

PLoS One. 2017 Feb 6;12(2):e0171117. doi: 10.1371/journal.pone.0171117. eCollection 2017.

14.

The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016.

Rizzo R, Fainardi E, Rouas-Freiss N, Morandi F.

J Immunol Res. 2017;2017:2309574. doi: 10.1155/2017/2309574. Epub 2017 Jan 4. No abstract available.

15.

Inhibition of T Cell Alloreactivity by Bronchial Epithelium Is Impaired in Lung Transplant Recipients, Through Pathways Involving TGF-β, IL-10 and HLA-G.

Dupin C, Lhuillier E, Létuvé S, Pretolani M, Thabut G, Mal H, Carosella E, Schilte C, Mordant P, Castier Y, Bunel V, Danel C, Rouas-Freiss N, Brugière O.

Transplantation. 2017 Sep;101(9):2192-2199. doi: 10.1097/TP.0000000000001553.

PMID:
27820781
16.

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases.

Morandi F, Rizzo R, Fainardi E, Rouas-Freiss N, Pistoia V.

J Immunol Res. 2016;2016:4326495. doi: 10.1155/2016/4326495. Epub 2016 Aug 29. Review.

17.

Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis.

Gineau L, Courtin D, Camara M, Ilboudo H, Jamonneau V, Dias FC, Tokplonou L, Milet J, Mendonça PB, Castelli EC, Camara O, Camara M, Favier B, Rouas-Freiss N, Moreau P, Donadi EA, Bucheton B, Sabbagh A, Garcia A.

Clin Infect Dis. 2016 Nov 1;63(9):1189-1197. Epub 2016 Jul 28.

PMID:
27470243
18.

Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G.

Du WJ, Reppel L, Leger L, Schenowitz C, Huselstein C, Bensoussan D, Carosella ED, Han ZC, Rouas-Freiss N.

Stem Cells Dev. 2016 Oct 1;25(19):1454-69. doi: 10.1089/scd.2016.0022. Epub 2016 Jul 27.

PMID:
27465875
19.

HLA-G: An Immune Checkpoint Molecule.

Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J.

Adv Immunol. 2015;127:33-144. doi: 10.1016/bs.ai.2015.04.001. Epub 2015 May 27. Review.

PMID:
26073983
20.

Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.

Brugière O, Thabut G, Krawice-Radanne I, Rizzo R, Dauriat G, Danel C, Suberbielle C, Mal H, Stern M, Schilte C, Pretolani M, Carosella ED, Rouas-Freiss N.

Am J Transplant. 2015 Feb;15(2):461-71. doi: 10.1111/ajt.12977. Epub 2014 Dec 8.

21.

Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use.

Peltzer J, Montespan F, Thepenier C, Boutin L, Uzan G, Rouas-Freiss N, Lataillade JJ.

Stem Cells Dev. 2015 Feb 1;24(3):329-44. doi: 10.1089/scd.2014.0327. Epub 2014 Oct 21.

PMID:
25203666
22.

High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy.

Sadissou I, d'Almeida T, Cottrell G, Luty A, Krawice-Radanne I, Massougbodji A, Moreau P, Moutairou K, Garcia A, Favier B, Rouas-Freiss N, Courtin D.

Malar J. 2014 Aug 12;13:312. doi: 10.1186/1475-2875-13-312.

23.

The role of HLA-class Ib molecules in immune-related diseases, tumors, and infections.

Morandi F, Fainardi E, Rizzo R, Rouas-Freiss N.

J Immunol Res. 2014;2014:231618. doi: 10.1155/2014/231618. Epub 2014 May 28. No abstract available.

24.

The emerging role of soluble HLA-G in the control of chemotaxis.

Morandi F, Rouas-Freiss N, Pistoia V.

Cytokine Growth Factor Rev. 2014 Jun;25(3):327-35. doi: 10.1016/j.cytogfr.2014.04.004. Epub 2014 May 13. Review.

PMID:
24882150
25.

Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy.

Montespan F, Deschaseaux F, Sensébé L, Carosella ED, Rouas-Freiss N.

J Immunol Res. 2014;2014:230346. doi: 10.1155/2014/230346. Epub 2014 Apr 30.

26.

The dual role of HLA-G in cancer.

Rouas-Freiss N, Moreau P, LeMaoult J, Carosella ED.

J Immunol Res. 2014;2014:359748. doi: 10.1155/2014/359748. Epub 2014 Mar 31. Review.

27.

Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.

Leibler C, Matignon M, Pilon C, Montespan F, Bigot J, Lang P, Carosella ED, Cohen J, Rouas-Freiss N, Grimbert P, Menier C.

Am J Transplant. 2014 May;14(5):1173-82. doi: 10.1111/ajt.12721. Epub 2014 Apr 14.

28.

In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.

Loumagne L, Baudhuin J, Favier B, Montespan F, Carosella ED, Rouas-Freiss N.

Int J Cancer. 2014 Nov 1;135(9):2107-17. doi: 10.1002/ijc.28845. Epub 2014 Apr 7.

29.

Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses.

Naji A, Menier C, Morandi F, Agaugué S, Maki G, Ferretti E, Bruel S, Pistoia V, Carosella ED, Rouas-Freiss N.

J Immunol. 2014 Feb 15;192(4):1536-46. doi: 10.4049/jimmunol.1300438. Epub 2014 Jan 22.

30.

Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population.

Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I, Poras I, Rebmann V, Carosella ED, Rouas-Freiss N, Moreau P, Donadi EA.

PLoS One. 2013 Oct 25;8(10):e71742. doi: 10.1371/journal.pone.0071742. eCollection 2013.

31.

Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.

Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sensébé L, Deschaseaux F.

Stem Cells. 2013 Nov;31(11):2296-303. doi: 10.1002/stem.1494. Review.

32.

Association of HLA-G 3' untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results.

Sabbagh A, Courtin D, Milet J, Massaro JD, Castelli EC, Migot-Nabias F, Favier B, Rouas-Freiss N, Moreau P, Garcia A, Donadi EA.

Tissue Antigens. 2013 Jul;82(1):53-8. doi: 10.1111/tan.12140.

PMID:
23745572
33.

Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue.

Deschaseaux F, Gaillard J, Langonné A, Chauveau C, Naji A, Bouacida A, Rosset P, Heymann D, De Pinieux G, Rouas-Freiss N, Sensébé L.

FASEB J. 2013 Aug;27(8):2977-87. doi: 10.1096/fj.13-227264. Epub 2013 Apr 16.

PMID:
23592762
34.

HLA-G 3' UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility.

Courtin D, Milet J, Sabbagh A, Massaro JD, Castelli EC, Jamonneau V, Bucheton B, Sese C, Favier B, Rouas-Freiss N, Moreau P, Donadi EA, Garcia A.

Infect Genet Evol. 2013 Jul;17:1-7. doi: 10.1016/j.meegid.2013.03.004. Epub 2013 Mar 26.

PMID:
23541412
35.

Association of HLA-G 3'UTR polymorphisms with response to malaria infection: a first insight.

Garcia A, Milet J, Courtin D, Sabbagh A, Massaro JD, Castelli EC, Migot-Nabias F, Favier B, Rouas-Freiss N, Donadi EA, Moreau P.

Infect Genet Evol. 2013 Jun;16:263-9. doi: 10.1016/j.meegid.2013.02.021. Epub 2013 Mar 14.

PMID:
23499774
36.

HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.

Zilberman S, Schenowitz C, Agaugué S, Benoît F, Riteau B, Rouzier R, Carosella ED, Rouas-Freiss N, Menier C.

Eur J Immunol. 2012 Jun;42(6):1599-608. doi: 10.1002/eji.201141761.

37.

Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.

Naji A, Menier C, Maki G, Carosella ED, Rouas-Freiss N.

Leukemia. 2012 Aug;26(8):1889-92. doi: 10.1038/leu.2012.62. Epub 2012 Mar 5. No abstract available.

PMID:
22441169
38.

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.

Agaugué S, Carosella ED, Rouas-Freiss N.

Blood. 2011 Jun 30;117(26):7021-31. doi: 10.1182/blood-2010-07-294389. Epub 2011 Apr 11.

PMID:
21482709
39.

Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.

Lesport E, Baudhuin J, Sousa S, LeMaoult J, Zamborlini A, Rouas-Freiss N, Carosella ED, Favier B.

Cell Mol Life Sci. 2011 Oct;68(20):3385-99. doi: 10.1007/s00018-011-0632-7. Epub 2011 Feb 20. Erratum in: Cell Mol Life Sci. 2011 Oct;68(20):3401.

PMID:
21337044
40.

The role of HLA-G in immunity and hematopoiesis.

Carosella ED, Gregori S, Rouas-Freiss N, LeMaoult J, Menier C, Favier B.

Cell Mol Life Sci. 2011 Feb;68(3):353-68. doi: 10.1007/s00018-010-0579-0. Epub 2010 Nov 30. Review.

PMID:
21116680
41.

Increased soluble human leukocyte antigen-G levels in peripheral blood from climbers on Mount Everest.

Bourguignon M, Yaghi L, Flajollet S, Radanne-Krawice I, Rouas-Freiss N, Lugrin D, Richalet JP, Carosella ED, Moreau P.

Hum Immunol. 2010 Nov;71(11):1105-8. doi: 10.1016/j.humimm.2010.08.011. Epub 2010 Aug 21.

PMID:
20732367
42.

Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection.

Souto FJ, Crispim JC, Ferreira SC, da Silva AS, Bassi CL, Soares CP, Zucoloto S, Rouas-Freiss N, Moreau P, Martinelli AL, Donadi EA.

J Viral Hepat. 2011 Feb;18(2):102-5. doi: 10.1111/j.1365-2893.2010.01286.x.

PMID:
20236238
43.

Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule.

Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED.

Tissue Antigens. 2010 Mar;75(3):201-6. doi: 10.1111/j.1399-0039.2009.01438.x. Epub 2009 Dec 30. Review.

PMID:
20047640
44.

Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance.

Bahri R, Naji A, Menier C, Charpentier B, Carosella ED, Rouas-Freiss N, Durrbach A.

J Immunol. 2009 Dec 1;183(11):7054-62. doi: 10.4049/jimmunol.0803054. Epub 2009 Nov 13.

45.

Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection.

LeBouder F, Khoufache K, Menier C, Mandouri Y, Keffous M, Lejal N, Krawice-Radanne I, Carosella ED, Rouas-Freiss N, Riteau B.

Hum Immunol. 2009 Dec;70(12):1016-9. doi: 10.1016/j.humimm.2009.07.026. Epub 2009 Aug 5.

PMID:
19664669
46.

Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology.

Menier C, Prevot S, Carosella ED, Rouas-Freiss N.

Hum Immunol. 2009 Dec;70(12):1006-9. doi: 10.1016/j.humimm.2009.07.021. Epub 2009 Aug 4.

PMID:
19660509
47.

Immunohistochemical study of HLA-G expression in lung transplant recipients.

Brugière O, Thabut G, Pretolani M, Krawice-Radanne I, Dill C, Herbreteau A, Poras I, Moreau P, Colombat M, Danel C, Dehoux M, Fournier M, Carosella ED, Rouas-Freiss N.

Am J Transplant. 2009 Jun;9(6):1427-38. doi: 10.1111/j.1600-6143.2009.02650.x.

48.

HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells.

Selmani Z, Naji A, Gaiffe E, Obert L, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.

Transplantation. 2009 May 15;87(9 Suppl):S62-6. doi: 10.1097/TP.0b013e3181a2a4b3.

PMID:
19424010
49.

Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.

Sheshgiri R, Rouas-Freiss N, Rao V, Butany J, Ramzy D, Krawice-Radanne I, Ross HJ, Carosella ED, Delgado DH.

J Heart Lung Transplant. 2008 May;27(5):522-7. doi: 10.1016/j.healun.2008.02.004.

PMID:
18442718
50.

Beyond the increasing complexity of the immunomodulatory HLA-G molecule.

Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J.

Blood. 2008 May 15;111(10):4862-70. doi: 10.1182/blood-2007-12-127662. Epub 2008 Mar 11. Review.

PMID:
18334671

Supplemental Content

Loading ...
Support Center